Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

ARTIFICIAL INTELLIGENCE BASED HEALTH, OPTIMISM, PURPOSE, AND ENDURANCE IN PALLIATIVE CARE FOR DEMENTIA

AI4HOPE

Dementia is caused by a range of illnesses and disorders that damage the brain either directly or indirectly. With the rise of the ageing population in the EU, dementia is becoming a serious problem. Digital health interventions have the potential to improve the accessibility and effectiveness of palliative care. Palliative care is an area where...

Funding Programme
Start Date
End Date
Total Funding
€ 6 419 025

Biomarker based diagnosis of rapid progressive dementias – optimisation of diagnostic protocols.

DEMTEST

DEMTEST has established a large European and global collaboration between national surveillance units and dementia research centres, facilitating cooperation between neurologists, neuropathologists and neuroscientists. We work on standardisation of tests that are currently available and harmonise their use between centers worldwide. We define...

Funding Programme
Start Date
End Date
Total Funding
€ 2 200 000

Biomarkers for Alzheimer’s disease and Parkinson’s disease.

BIOMARKAPD

Neurodegenerative disorders, represented mostly by Alzheimer's disease (AD) and Parkinson's disease (PD), are characterised by progressive neuronal impairment and death. In spite of the brain's known capacity for regeneration, lost neurons generally cannot be replaced. Therefore, drugs aimed at inhibiting neurodegenerative processes are likely to...

Funding Programme
Start Date
End Date
Total Funding
€ 449 066

Chair of Neuroinformatics

CONI

Neuroinformatics (NI) is now an essential approach in brain research, to organise, analyse, integrate and interpret an increasing volume of diverse, multi-dimensional, fine-grain neuroscience data. University of Ljubljana's (UL's) challenges in this field are suboptimal research management & open innovation (OI), slow pace of structural changes...

Funding Programme
Start Date
End Date
Total Funding
€ 2 499 996
European Countries Involved

Disrupting the Migraine continuum of care for resource constrained settings

TARA

Chronic migraine is defined as a headache persistent for more than 3 months or a severe headache persistent for more than 15 days within a month. It affects approximately 2% of the world population. The World Health Organization classifies severe migraine attacks as among the most disabling illnesses, comparable to dementia and quadriplegia...

Funding Programme
Start Date
End Date
Total Funding
€ 4 380 708
European Countries Involved

In-Touch: Implementation of a person-centered palliative care iNtervention To imprOve comfort, QUality of Life and social engagement of people with advanced dementia in Care Homes

In-Touch

Challenge. Caring for the increasing numbers of people across Europe with advanced dementia and palliative care needs who live in care homes is difficult and demanding. People with advanced dementia can be immobile, non-verbal and unable to take part in day-to-day activities. They can be unsettled or agitated, with low quality-of-life and elevated...

Funding Programme
Start Date
End Date
Total Funding
€ 5 723 637

Models of patient engagement for Alzheimer’s disease

MOPEAD

Dementia researchers are increasingly focusing their efforts on finding ways to prevent the onset of dementia symptoms in the first place, and for this they need to work with people who are still in the very earliest stages of the disease. The MOPEAD project aims to identify and test different models for engaging with this important group and...

Funding Programme
Start Date
End Date
Total Funding
€ 4 591 968
European Countries Involved

PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE

PROMINENT

Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million people are currently living with dementia, at a cost of over 400 billion EUR annually. Comorbidities with these conditions are frequent and a major obstacle to optimal diagnosis and management. Recent advances...

Funding Programme
Start Date
End Date
Total Funding
€ 6 069 750
European Countries Involved

Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty

COMFORTAGE

COMFORTAGE is a joint effort of medical experts (i.e., neurologists, psychiatrists, neuropsychologists, nurses, memory clinics), social scientists and humanists, technical experts (i.e., data scientists, AI experts, robotic experts) and Digital Innovation Hubs to establish a pan European framework for Community-based, Integrated and People-Centric...

Funding Programme
Start Date
End Date
Total Funding
€ 17 591 490

 Indoor and outdoor NITICSplus solution for dementia challenges

IONIS

Due to ageing of the populations, increasing number of elderly people experience progressive cognitive decline and suffer from dementia including Alzheimer’s disease. Symptoms affecting people with dementia create an enormous challenge to healthcare and social support systems, as well as individual caregivers. Needs of people with cognitive decline...

Funding Programme
Start Date
End Date
Total Funding
€ 2 309 150
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).